Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosis

Reuben Malloy(The University of Queensland), Yoon‐Kyo An(Mater Hospital), Jakob Begun(Translational Research Institute), Richard Fernandes(The University of Queensland)
BMJ Case Reports
December 1, 2022
Cited by 8


Related Papers